These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3761160)

  • 1. [Central depressant effect of barbituric acid and N,5,5-triallylbarbituric acid in mice].
    Tateoka Y; Kimura T; Yamazaki F; Watanabe K; Yamamoto I
    Yakugaku Zasshi; 1986 Jun; 106(6):504-10. PubMed ID: 3761160
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacologic activity of a group of new barbituric acid derivatives.
    Pelczarska A; Szaga B
    Arch Immunol Ther Exp (Warsz); 1969; 17(4):547-54. PubMed ID: 5817418
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the structure-activity relationship of allyl substituted oxopyrimidines searching for the novel antagonist or agonist of barbiturates to the sleep mechanism based on the uridine receptor theory--barbituric acid to uridine (part I)].
    Yamamoto I
    Yakugaku Zasshi; 2005 Jan; 125(1):73-120. PubMed ID: 15635282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of central nervous system stimulant and depressant drugs in the intact animal. 3. Dual action of 5-ethyl-5-(1,3-dimethylbutyl)barbiturate, dilantin and beta-methyl-beta-eta-propylglutarimide.
    Shulman A; Laycock GM
    Eur J Pharmacol; 1967 Oct; 2(1):17-25. PubMed ID: 4384752
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological studies on zopiclone.
    Julou L; Bardone MC; Blanchard JC; Garret C; Stutzmann JM
    Pharmacology; 1983; 27 Suppl 2():46-58. PubMed ID: 6142468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on new hypnotic drugs. Communication 7. Pharmacological properties of new derivatives of barbituric acid and hydantoin].
    WILIMOWSKI M; GIELDANOWSKI J; KEDZIERSKA L
    Arch Immunol Ther Exp (Warsz); 1960; 8():371-5. PubMed ID: 13785286
    [No Abstract]   [Full Text] [Related]  

  • 7. Depressant and convulsant barbiturates both inhibit neuronal nicotinic acetylcholine receptors.
    Watanabe I; Andoh T; Furuya R; Sasaki T; Kamiya Y; Itoh H
    Anesth Analg; 1999 Jun; 88(6):1406-11. PubMed ID: 10357353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interactions of tetrazol-uracil derivative compounds (VMI-502 and VMI-510) with some central depressive agents].
    Todorov D; Paskov D
    Agressologie; 1971; 12():Spec No C:95-101. PubMed ID: 5290180
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolution of optical isomers of 5-allyl-5-(beta-hydroxypropyl)-barbituric acid (Ipronal, Axeen) and their pharmacological activity.
    Bobranski B; Wilimowski M; Barczynska J; Seniuta R; Sedzimirska B; Witkowska M
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):299-308. PubMed ID: 4147382
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of sedative and anticonvulsant barbiturates on specific [3H]GABA binding to membrane preparations from rat brain cortex.
    Whittle SR; Turner AJ
    Biochem Pharmacol; 1982 Sep; 31(18):2891-5. PubMed ID: 6291550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacology of flunitrazepam (provided under the trade name Rohypnol)].
    Kapp W
    Klin Anasthesiol Intensivther; 1978; (17):1-7. PubMed ID: 28431
    [No Abstract]   [Full Text] [Related]  

  • 12. The central action of 1-p-dimethylaminophenyl-5-allyl-5-(beta-hydroxypropyl) barbituric acid and the corresponding lactone.
    Hano J; Sypniewska M; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1978; 30(1):55-61. PubMed ID: 565512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2,5-diaryl-substituted 1,3,4-oxadiazoles: synthesis and preliminary pharmacological investigation].
    Mazzone G; Bonina F; Puglisi G; Panico AM; Arrigo Reina R
    Farmaco Sci; 1984 May; 39(5):414-20. PubMed ID: 6734817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-(2-Cyclohexylideneethyl)-5-ethyl barbituric acid (CHEB): correlation of hypnotic and convulsant properties with alterations of synaptosomal 45Ca2+ influx.
    Chandler LJ; Leslie SW; Gonzales R
    Eur J Pharmacol; 1986 Jul; 126(1-2):117-23. PubMed ID: 2875881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convulsant, anticonvulsant and anaesthetic barbiturates. 5-Ethyl-5-(3'-methyl-but-2'-enyl)-barbituric acid and related compounds.
    Andrews PR; Jones GP; Lodge D
    Eur J Pharmacol; 1979 Apr; 55(2):115-20. PubMed ID: 456410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsants. 3. Phenobarbital and mephobarbital derivatives.
    Vida JA; Hooker ML
    J Med Chem; 1973 Jun; 16(6):602-5. PubMed ID: 4714988
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticonvulsants. 2. Acyloxymethyl and halomethyl derivatives of barbituric acid and diphenylhydantoin.
    Vida JA; Wilber WR; Reinhard JF
    J Med Chem; 1971 Mar; 14(3):187-9. PubMed ID: 5552206
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interactions and incompatibilities of drugs acting upon the central nervous system. 1. Sedatives and hypnotics].
    Estler CJ
    Fortschr Med; 1973 Apr; 91(12):527-30. PubMed ID: 4702401
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypnotics and sedatives; review. II. Barbituric acid derivatives].
    WESTERLING R
    Sven Farm Tidskr; 1953 Feb; 57(5):81-90. PubMed ID: 13077170
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of depressant properties of alcohol or barbiturate in combination with aqueous suspended delta 9-tetrahydrocannabinol in rats.
    Phillips RN; Brown DJ; Forney RB
    J Forensic Sci; 1971 Apr; 16(2):152-61. PubMed ID: 5557637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.